1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Hunter, H.N. Fulton, D.B. Ganz, T. Vogel, H.J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 277 37597 37603 10.1074/jbc.M205305200 12138110 The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. 2002 10.2210/pdb1m4e/pdb pdb_00001m4e 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 2203.828 Hepcidin Hepcidin-20 (residues 65-84) 1 syn polymer Liver-expressed antimicrobial peptide, LEAP-1, Putative liver tumor regressor, PLTR, Hepc20 no no ICIFCCGCCHRSKCGMCCKT ICIFCCGCCHRSKCGMCCKT A polypeptide(L) n n n n n n n n n n n n n n n n n n n n database_2 pdbx_nmr_software pdbx_nmr_spectrometer pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2002-11-06 1 1 2008-04-28 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _pdbx_nmr_spectrometer.model The solution structure of hepcidin-25 RCSB Y RCSB 2002-07-02 REL REL The sequence of the protein is naturally found in Homo sapiens. The protein was chemically synthesized. sample This structure was determined using standard 2D homonuclear techniques. structures with the lowest energy 100 20 2D NOESY 2D TOCSY 13C-HSQC Diffusion 3.2 ambient 298 K the structures are based on 285 NOE-derived distance constraints, 17 dihedral angle restraints, 5 distance restraints from hydrogen bonds. simulated annealing, molecular dynamics, matrix relaxation, torsion angle dynamics 1 lowest energy 0.78mM hepcidin-20 90% H2O/10% D2O Bruker collection XwinNMR 2.6 Brunger et al structure solution CNS 1.1 Delaglio, F. processing NMRPipe 3.4 Brunger et al refinement CNS 1.1 500 Bruker AVANCE 700 Bruker AVANCE ILE 1 n 1 ILE 1 A CYS 2 n 2 CYS 2 A ILE 3 n 3 ILE 3 A PHE 4 n 4 PHE 4 A CYS 5 n 5 CYS 5 A CYS 6 n 6 CYS 6 A GLY 7 n 7 GLY 7 A CYS 8 n 8 CYS 8 A CYS 9 n 9 CYS 9 A HIS 10 n 10 HIS 10 A ARG 11 n 11 ARG 11 A SER 12 n 12 SER 12 A LYS 13 n 13 LYS 13 A CYS 14 n 14 CYS 14 A GLY 15 n 15 GLY 15 A MET 16 n 16 MET 16 A CYS 17 n 17 CYS 17 A CYS 18 n 18 CYS 18 A LYS 19 n 19 LYS 19 A THR 20 n 20 THR 20 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N CYS 5 A N CYS 5 A O GLY 15 A O GLY 15 1 A ILE 3 -69.98 96.45 1 A PHE 4 -50.34 106.07 1 A CYS 9 -129.28 -56.35 1 A HIS 10 -73.35 -137.96 1 A CYS 18 -90.15 55.08 2 A PHE 4 -45.18 93.14 2 A CYS 9 -129.04 -55.45 2 A HIS 10 -81.88 -137.17 2 A CYS 18 -102.60 51.37 3 A PHE 4 -43.96 91.61 3 A CYS 9 -129.14 -54.72 3 A HIS 10 -80.04 -136.88 4 A PHE 4 -44.52 99.33 4 A CYS 9 -129.37 -54.97 4 A HIS 10 -75.81 -135.66 5 A ILE 3 -68.92 96.64 5 A PHE 4 -49.68 99.69 5 A CYS 6 -90.39 59.85 5 A CYS 9 -128.71 -55.87 5 A HIS 10 -77.37 -132.30 5 A CYS 18 -105.76 49.75 6 A PHE 4 -44.26 93.24 6 A CYS 9 -128.93 -52.78 6 A HIS 10 -73.46 -142.01 6 A CYS 18 -98.79 52.03 6 A LYS 19 -110.67 56.87 7 A PHE 4 -46.34 106.12 7 A CYS 9 -129.46 -58.08 7 A HIS 10 -75.80 -128.88 8 A PHE 4 -50.27 102.79 8 A CYS 6 -91.18 58.14 8 A CYS 9 -129.21 -64.82 8 A HIS 10 -84.07 -122.76 9 A PHE 4 -50.89 98.99 9 A CYS 9 -129.60 -57.13 9 A HIS 10 -79.63 -130.45 9 A LYS 19 -29.86 -45.09 10 A PHE 4 -47.52 105.46 10 A CYS 9 -128.64 -66.23 10 A HIS 10 -120.84 -52.95 11 A PHE 4 -50.54 104.89 11 A CYS 9 -129.23 -56.63 11 A HIS 10 -74.64 -137.15 11 A LYS 19 -32.08 135.19 12 A ILE 3 -66.85 97.39 12 A PHE 4 -49.74 104.65 12 A CYS 9 -128.96 -54.31 12 A HIS 10 -75.26 -138.57 13 A ILE 3 -61.56 98.52 13 A PHE 4 -53.09 94.66 13 A CYS 9 -129.05 -55.50 13 A HIS 10 -74.87 -140.21 14 A PHE 4 -47.78 105.18 14 A CYS 8 -66.77 -73.95 14 A HIS 10 -74.76 -128.71 15 A PHE 4 -47.88 106.78 15 A CYS 9 -128.70 -53.36 15 A HIS 10 -73.15 -142.22 15 A LYS 19 -49.88 153.02 16 A ILE 3 -62.71 97.63 16 A PHE 4 -50.76 104.95 16 A CYS 8 -74.32 -75.12 16 A HIS 10 -71.96 -137.11 17 A PHE 4 -46.93 105.89 17 A CYS 9 -129.22 -56.80 17 A HIS 10 -74.98 -139.74 18 A ILE 3 -67.52 96.96 18 A PHE 4 -48.83 107.61 18 A CYS 9 -128.84 -56.52 18 A HIS 10 -73.27 -141.01 19 A ILE 3 -62.96 97.73 19 A PHE 4 -49.46 107.36 19 A CYS 9 -128.91 -64.75 19 A HIS 10 -80.61 -135.13 20 A ILE 3 -62.67 97.77 20 A PHE 4 -52.13 100.38 20 A CYS 9 -129.47 -62.49 20 A HIS 10 -79.43 -126.77 Solution Structure of Hepcidin-20 1 N N disulf 2.031 A CYS 2 A SG CYS 2 1_555 A CYS 18 A SG CYS 18 1_555 disulf 2.030 A CYS 5 A SG CYS 5 1_555 A CYS 17 A SG CYS 17 1_555 disulf 2.033 A CYS 6 A SG CYS 6 1_555 A CYS 14 A SG CYS 14 1_555 disulf 2.086 A CYS 8 A SG CYS 8 1_555 A CYS 9 A SG CYS 9 1_555 ANTIMICROBIAL PROTEIN strand-loop-strand, beta-sheet, hairpin loop, ANTIMICROBIAL PROTEIN HEPC_HUMAN UNP 1 65 P81172 ICIFCCGCCHRSKCGMCCKT 65 84 1M4E 1 20 P81172 A 1 1 20 2 anti-parallel A ILE 3 A ILE 3 A CYS 6 A CYS 6 A CYS 14 A CYS 14 A CYS 17 A CYS 17